Using next-generation RNA sequencing combined with data from local sources and The Cancer Genome Atlas, U-M researchers have uncovered the gene signature for chromophobe renal cell carcinoma (ChRCC).

A new study examines why different types of gut bacteria impact the development or suppression of colorectal cancer in mice.

Antiandrogen treatment is associated with heart and neurological problems and didn’t increase survival for this group of men, a U-M analysis finds.

Study: Commercially available antibodies used to investigate modification of key cancer braking mechanism aren’t fully reliable

For children diagnosed with high risk brain tumors, an exclusive global network helps promising clinical trials underway.

Research behind a drug compound that causes complete remission of a leukemia subtype in mouse models has recently spurred a human clinical trial.

Glioblastoma is a deadly brain cancer with little treatment options available, but Michigan Medicine researchers are working in the lab to change that.

In mouse models, the work uncovers a new potential target to improve immunotherapy approaches to the deadly disease.

Research suggests wearable temperature monitors may offer an inexpensive, non-invasive way to detect a life-threatening bone-marrow transplant complication.

An innovative way of assessing clinical trial-related imaging could reduce the kinds of errors that can distort results, study finds.

The University of Michigan Rogel Cancer Center’s Top 10 stories of 2019.

New approach to targeting STAT3 achieves near complete elimination of leukemia and lymphoma tumors in mouse models.

Michigan Medicine’s C.S. Mott Children’s Hospital experts make special sequencing tests routine in treating high risk pediatric brain tumors.

Low-risk thyroid cancer patients may not see health benefits from increased testing after surgery.

A Michigan Medicine survey reveals patients could feel more empowered and better understand their diagnosis after speaking directly with a pathologist.